Product Portfolio Development

Product Portfolio Development

Patent and exclusivity expiries, sales trends, active ingredient availability, existing competition in various markets, barriers to entry – these are just some of the pieces of information you need to make decisions about your product portfolio and whether to develop a product in house or license it from partners. Turning to one source for this information can save you valuable time and help you to the most informed decisions, faster.

Thomson Reuters can help you quickly and thoroughly:

  • Gather and interpret data on specific opportunities and markets
  • Assess current & future market shares/sales
  • Proactively assess competitors based on their drug pipeline and also their potential to advance their development drugs to market
  • Target products for development, monitor your competition, and find partners 
  • See which products are losing patent and exclusivity protection in a given time frame in a particular country